skip to content
Primary navigation


DrugMovantik™ (naloxegol oxalate tablets) [AstraZeneca]

November 2015

Therapeutic area - Opioid induced constipation

Approval criteria

The patient must meet all of the following criteria:

  • Is 18 years of age or older 
  • Is taking opioids for chronic, non-cancer pain 
  • Is documented to have opioid induced constipation 
  • Has not tolerated or has had inadequate response to one-month trials of a stimulant laxative (e.g., bisacodyl; sennosides) and polyethylene glycol 3350 or other osmotic laxative (e.g., sorbitol, lactulose, magnesium citrate, magnesium hydroxide, glycerin rectal suppositories)

Quantity limit

Maximum one tablet daily (34 tablets per 34 days)


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top